29. Jahrestagung der Kind-Philipp-Stiftung für pädiatrisch-onkologische Forschung

Abstracts (HTML) List of Authors

Mahnken, A

Comparison of different tag purification approaches to create GATA1-/GATA1 s-centered protein interaction networks

Maluski, M

Engineered precursor T cells from human umbilical cord blood using an alpharetroviral vector platform
CAR-engineered precursor T cells (preTs) for leukemia control after hematopoietic stem cell transplantation

Mangolini, M

Aberrant transcriptional pathways in t(12;21) Acute Lymphoblastic Leukemia

Marek, M

Development of novel HDAC inhibitors to selectively co-inhibit HDAC8 and HDAC10 in childhood cancer

Marencke, N

Impact of the gene expression of natural killer cell receptors and their ligands for treatment response and prognosis in pediatric acute lymphoblastic leukemia

Marschalek, R

The IRX1/HOXA connection: insights into a novel t(4;11)-specific cancer mechanism

Martín, DH

Epigenetic profiling identifies MIR10A-5 p as a putative tumor suppresor in Ewing sarcoma and rhabdomyosarcoma

Martinez-Soria, N

t(8;21) Acute Myeloid Leukaemia Requires Active CCND-CDK4/6

Matthes, LA

Nup98-Kdm5a, induced via CRISPR-Cas9 genome editing, transforms murine hematopoietic stem cells

McKenzie, L

t(8;21) Acute Myeloid Leukaemia Requires Active CCND-CDK4/6

Metzler, M

Prediction of Acute Lymphoblastic Leukemia Maintenance Therapy
Quantification of genomic EWSR1 fusion sequences from plasma of Ewing sarcoma (EwS) patients for therapy monitoring and relapse detection
A Bioinformatics Approach to Pediatric Hematology Reference Intervals

Meyer, HE

The MCM complex is a critical node in the miR-183 signaling network of MYCN-amplified neuroblastoma cells

Meyer, LH

Targeting p53-MDM 2 interaction in pediatric ALL
Targeting mutant TP53 in ALL
Efficacy of the BH3-mimetic ABT-199 in acute lymphoblastic leukemia
Pre-BCR expression predicts sensitivity to SYK inhibition in B-cell acute lymphoblastic leukemia
Effective targeting of Acute Lymphoblastic Leukemia (ALL) by CD70 directed immunotherapy

Miller, AK

Development of novel HDAC inhibitors to selectively co-inhibit HDAC8 and HDAC10 in childhood cancer

Moericke, A

Impact of the gene expression of natural killer cell receptors and their ligands for treatment response and prognosis in pediatric acute lymphoblastic leukemia

Moll, N

Targeting p53-MDM 2 interaction in pediatric ALL

Mora, J

Epigenetic profiling identifies MIR10A-5 p as a putative tumor suppresor in Ewing sarcoma and rhabdomyosarcoma

Morán, S

Epigenetic profiling identifies MIR10A-5 p as a putative tumor suppresor in Ewing sarcoma and rhabdomyosarcoma

Möricke, A

Prognostic impact of IKZF1 deletions in association with vincristine-dexamethasone pulses during maintenance treatment of childhood acute lymphoblastic leukemia on trial AIEOP-BFM ALL 95
TP53 single nucleotide variants (SNV) in patients developing second malignant neoplasms after treatment for childhood acute lymphoblastic leukemia

Müschen, M

Pre-BCR expression predicts sensitivity to SYK inhibition in B-cell acute lymphoblastic leukemia

Mynarek, M

Histological and genetic features predict outcome in infratentorial ependymomas of childhood